Xenetic Biosciences, Inc.
XBIO· Nasdaq
XBIOXenetic Biosciences, Inc.
Filed Aug 19, 2015 · 10-Q · 50 days after period end · 0001019687-15-003198
| Metric | Q2 2015 | Q2 2014 | Q2 2013 |
|---|---|---|---|
| Revenue | — | — | $1.00M |
| Net Income | -$1.13M | -$2.76M | -$938.33K |
| EPS Diluted | -$0.27 | -$0.02 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Xenetic Biosciences, Inc. · CIK 1534525 · Engraved from SEC EDGAR
ended Jun 30, 2015 · filed Aug 19, 2015 · 50 d after period end
